对抗体和其抗原结合片段工程改造以改善与FcRn的结合亲和力的方法是本领域中众所周知的,参见例如Vaughn,D.等人《,结构(Structure)》,6(1):63‑73(1998);Kontermann,R.等人《,抗体工程(Antibody Engineering)》,第1卷,第27章:改善PK的Fc区工程改造(Engineering of the Fc region for improved PK),Springer出版...
Novel anti-FGFR2B antibodyAnti-FGFR2b antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and uses thereof are provided.
英文名称:FGFR2 Polyclonal Antibody 英文同义词:FGFR2 Polyclonal Antibody CAS号: 分子式: 分子量:0 EINECS号: 信息错误报告 您的Email: 按国家浏览FGFR2 Polyclonal Antibody国外供应商中国供应商 FGFR2 Polyclonal Antibody推荐供应商 建议您优先选择企业会员,我们对企业会员产品有严格审核。
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma (vol 38, pg 2418, 2020) 来自 国家科技图书文献中心 喜欢 0 阅读量: 31 作者: DVT Catenacci,D Rasco,J Lee,SY Rha,KW Lee,YJ Bang,J...
对抗体和其抗原结合片段工程改造以改善与fcrn的结合亲和力的方法是本领域中众所周知的,参见例如vaughn,d.等人,《结构(structure)》,6(1):63-73(1998);kontermann,r.等人,《抗体工程(antibody engineering)》,第1卷,第27章:改善pk的fc区工程改造(engineering of the fc region for improved pk),springer出版,...
2. Gemo AT, et al. FPA144: Atherapeutic antibody for treating patients with gastric cancers bearing FGFR2gene amplification. Cancer Res. 2014;74(19 Suppl). (作者:张洪涛,笔名“一节生姜”。宾夕法尼亚大学医学院病理及实验医药系研究副教授,研究领域:癌症的靶向治疗以及免疫治疗。著有科普读物:《吃什...
A novel anti fgfr2b antibodyThe present disclosure provides an anti fgfr2b antibody or an antigen binding fragment, an isolated polynucleotide encoding it, a pharmaceutical composition comprising it, and its use.
An antibody binding to FGFR2 IIIB and provides an antibody to afcosylated. A composition comprising antibodies that bind to FGFR2 IIIB, and at least 95% of the antibodies in the composition are afocylated. In some embodiments, there is provided a method of treating a cancer, including ...
Composition containing anti-FGFR2 antibody and other agentCombination of antibodies and other agents that bind to human type 2 fibroblast growth factor receptor (hFGFR2).塩瀬 能伸石田 さおり
A preparation system of the polypeptide comprises a recombinant vector, a host cell and a preparation method, an antibody of FGFR2b ectodomain and a preparation method thereof as well as a fusion polypeptide, an antagonist and the like of the FGFR2B ectodomain and Fc domain. The invention ...